Cite

MLA Citation

    Mathurin Fumery et al.. “Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn's Disease: A Multicentre Study.” Journal of Crohn's and colitis, vol. 15, 2021, pp. 222–227. http://access.bl.uk/ark:/81055/vdc_100121927727.0x000024
  
Back to record